Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease

Neuropathology and Applied Neurobiology

Volumn 27, Issue 5, 2001, Pages 362-372

  Hishikawa, N ^a   Hashizume, Y ^b   Yoshida, M ^a   Sobue, G ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

synuclein; Argyrophilic glial inclusion; Catecholaminergic neurones; Lewy body; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; PROTEIN ANTIBODY; TAU PROTEIN; TYROSINE 3 MONOOXYGENASE;

AGED; ARGYROPHILIA; ARTICLE; AUTOPSY; BRAIN REGION; CATECHOLAMINE NERVE CELL; CELL DENSITY; CELL INCLUSION; CELL LOSS; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; GLIA CELL; GLIOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LOCUS CERULEUS; MALE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; STAINING; SUBSTANTIA NIGRA; VAGUS NERVE DORSAL NUCLEUS;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; CENTRAL NERVOUS SYSTEM; FEMALE; HUMANS; INCLUSION BODIES; LEWY BODIES; LEWY BODY DISEASE; MALE; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURITES; NEUROGLIA; NEURONS; PARKINSON DISEASE; SILVER STAINING; SYNUCLEINS; TYROSINE 3-MONOOXYGENASE; UBIQUITIN;

EID: 0034756740     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2990.2001.00345.x     Document Type: Article

References (43)

1. Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/α-synuclein
2. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies
3. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy
4. Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies
5. Cortical degeneration in progressive supranuclear palsy. A comparison with cortical-basal ganglionic degeneration
6. Astrocytes expressing hyperphosphorylated tau protein without glial fibrillary tangles in argyrophilic grain disease
7. Silver staining method for demonstrating Lewy bodies in Parkinson's disease and argyrophilic oligodendrocytes in multiple system atrophy
8. Argyrophilic grains: Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes
9. Tau protein in the glial cytoplasmic inclusions of multiple system atrophy can be distinguished from abnormal tau in Alzheimer's disease
10. Widespread cytoskeletal pathology characterizes corticobasal degeneration
11. Multiple-system atrophy: A new α-synuclein disease?
12. Do oligodendrocytes mediate iron regulation in the human brain?
13. Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease
14. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
15. Thorn-shaped astrocytes: Possibly secondarily induced tau-positive glial fibrillary tangles
16. Glial fibrillary tangles and argyrophilic threads: Classification and disease specificity
17. Glial tau pathology in neurodegenerative diseases: Their nature and comparison with neuronal tangles
18. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity
19. Neuronal and glial tau-positive inclusions in diverse neurologic disease share common phosphorylation characteristics
20. Overview of morphological changes in Parkinson's disease
21. Dementia with grains (Argyrophilic grain disease)
22. Decrease of medullary catecholaminergic neurons in multiple system atrophy and Parkinson's disease and their preservation in amyotrophic lateral sclerosis
23. Astrocytic plaques and tuft of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy
24. Pathological basis for neurotransmitter changes in Parkinson's disease
25. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
26. Immunocytochemical localisation of transferrin in the human brain
27. Damage to dopamine systems differs between Parkinson's disease and Alzheimer's disease with parkinsonism
28. Oligodendroglial microtubular tangles in olivoponto-cerebellar atrophy
29. Argyrophilic/tau-positive glial inclusions in parkinsonism-dementia complex of Guam
30. Glial cytoplasmic inclusions in CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome)
31. α-synuclein in Lewy bodies
32. α-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
33. Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies
34. Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
35. Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders
36. Argyrophilic grain disease: Widespread hyperphosphorylation of tau protein in limbic neurons
37. Argyrophilic grain disease: Distribution of grains in patients with and without dementia
38. Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α-synuclein
39. NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains
40. Accumulation of α-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy
41. Gallyas-positive, tau-negative glial inclusions in Parkinson's disease midbrain
42. α-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy
43. Appearance of paired nucleated, tau-positive glia in patients with progressive supranuclear palsy brain tissue